 LexaGene Holdings Inc., a molecular diagnostics company developing fully-automated rapid pathogen detection systems, has announced the adoption of new corporate governance charters and policies. The company said its board of directors adopted a new audit committee charter, a compensation committee charter, a nominating and corporate governance charter, a cyber security policy, and a code of business conduct and ethics. 